tiprankstipranks
Trending News
More News >
AFYREN (FR:ALAFY)
:ALAFY
Advertisement

AFYREN (ALAFY) AI Stock Analysis

Compare
0 Followers

Top Page

FR:ALAFY

AFYREN

(Frankfurt:ALAFY)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 4o)
Rating:44Neutral
Price Target:
€2.50
▲(1.21% Upside)
AFYREN's stock score is primarily impacted by its financial performance challenges, including negative profitability and cash flow issues. Technical indicators also show weak momentum, and valuation metrics are unattractive due to negative earnings. The lack of earnings call data and corporate events further limits positive influences on the score.

AFYREN (ALAFY) vs. iShares MSCI France ETF (EWQ)

AFYREN Business Overview & Revenue Model

Company DescriptionAFYREN (ALAFY) is a French biotechnology company focused on creating sustainable and renewable biochemical products. It operates primarily in the green chemistry sector, using fermentation processes to convert biomass into valuable bio-based chemicals. AFYREN's core products include organic acids and other bio-based compounds used in various industries such as food and feed, fragrances and flavors, lubricants, and life sciences.
How the Company Makes MoneyAFYREN makes money by producing and selling bio-based chemicals derived from renewable resources. The company utilizes patented fermentation technology to convert agricultural by-products into high-value organic acids and other sustainable chemicals. AFYREN generates revenue through the sale of these products to industries that require bio-based alternatives for traditional petrochemical products. Key revenue streams include direct sales contracts with manufacturers in sectors like food and beverages, cosmetics, and pharmaceuticals. Partnerships with industry players and investments in scaling production capacity also contribute to AFYREN's financial performance.

AFYREN Financial Statement Overview

Summary
AFYREN faces significant operational and profitability challenges, with negative margins and cash flow issues. Despite a strong equity position and low leverage, the company needs to improve revenue growth and operational efficiency. Liquidity from cash reserves provides some buffer, but sustained operational improvements are crucial.
Income Statement
40
Negative
The company has seen a decline in revenue over the past year, with a revenue decrease from €3.38 million in 2023 to €2.86 million in 2024, indicating a negative growth rate of approximately -15%. The gross profit margin is negative at -6.08% for 2024, highlighting challenges in covering its cost of goods sold. Net profit margin remains deeply negative, reflecting ongoing losses, which is a concern for profitability. Additionally, EBIT and EBITDA margins are negative, indicating operating inefficiencies.
Balance Sheet
55
Neutral
The balance sheet shows a strong equity base with a debt-to-equity ratio of 0.06, suggesting low leverage and reduced financial risk. However, the equity ratio of 90% underscores the company's reliance on equity financing. Return on equity remains negative due to continued net losses, which is a concern. The company's cash position is strong, which provides liquidity support.
Cash Flow
50
Neutral
Operating cash flow is negative, indicating the company is not generating sufficient cash from its operations. Free cash flow has also declined, reflecting challenges in cash generation. The operating cash flow to net income ratio is above 1, which suggests that the company is able to translate a portion of its net losses into cash flow, albeit insufficiently to cover capital expenditures.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.70M2.86M3.38M3.46M3.04M3.99M
Gross Profit-1.83M-174.00K645.00K1.06M1.47M2.91M
EBITDA-4.30M-8.81M-8.59M-4.71M-2.78M476.00K
Net Income-11.36M-9.75M-9.59M-9.20M-3.61M-2.13M
Balance Sheet
Total Assets51.46M58.56M70.43M84.82M93.15M35.89M
Cash, Cash Equivalents and Short-Term Investments27.62M33.65M49.66M62.40M67.36M9.51M
Total Debt2.70M3.31M4.79M8.54M8.95M9.40M
Total Liabilities5.30M5.86M8.63M13.84M15.29M16.32M
Stockholders Equity46.16M52.70M61.80M70.98M77.86M19.57M
Cash Flow
Free Cash Flow-4.61M-5.84M-5.60M-3.83M-3.06M-872.00K
Operating Cash Flow-4.38M-5.62M-5.04M-3.30M-2.71M-387.00K
Investing Cash Flow-11.01M-9.11M-3.08M-362.00K-436.00K-13.55M
Financing Cash Flow-881.00K-1.28M-4.66M-1.14M60.77M21.65M

AFYREN Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.47
Price Trends
50DMA
2.52
Negative
100DMA
2.54
Negative
200DMA
2.16
Positive
Market Momentum
MACD
-0.01
Positive
RSI
47.52
Neutral
STOCH
36.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALAFY, the sentiment is Neutral. The current price of 2.47 is below the 20-day moving average (MA) of 2.52, below the 50-day MA of 2.52, and above the 200-day MA of 2.16, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 47.52 is Neutral, neither overbought nor oversold. The STOCH value of 36.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:ALAFY.

AFYREN Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
44
Neutral
€65.01M-22.07%-3.05%-16.40%
44
Neutral
€146.28M-3.79-16.58%90.91%-21.88%
44
Neutral
€154.71M-4.14-40.50%209.99%-16.49%
38
Underperform
€73.49M-8.03-7.96%76.56%13.76%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:ALAFY
AFYREN
2.47
-0.30
-10.83%
FR:ALCRB
Carbios SA
8.68
-5.26
-37.73%
FR:ALHGR
Hoffmann Green Cement Technologies SA
4.47
-2.23
-33.23%
FR:ALMOU
Moulinvest SA
19.70
5.75
41.23%
FR:ALCOG
Cogra 48 SA
4.62
-2.30
-33.24%
FR:LHYFE
Lhyfe SA
3.18
-0.41
-11.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2025